Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema after an inadequate response to prior therapy

  • Technology appraisal guidance
  • TA271
  • Published: 

This guidance has been updated and replaced by NICE technology appraisal guidance 301.